» Articles » PMID: 27137106

Hypothalamic-pituitary, Ovarian and Adrenal Contributions to Polycystic Ovary Syndrome

Overview
Publisher Elsevier
Date 2016 May 4
PMID 27137106
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is a prevalent heterogeneous disorder linked with disturbances of reproductive, endocrine and metabolic function. The definition and aetiological hypotheses of PCOS are continually developing to incorporate evolving evidence of the syndrome, which appears to be both multifactorial and polygenic. The pathophysiology of PCOS encompasses inherent ovarian dysfunction that is strongly influenced by external factors including the hypothalamic-pituitary axis and hyperinsulinaemia. Neuroendocrine abnormalities including increased gonadotrophin-releasing hormone (GnRH) pulse frequency with consequent hypersecretion of luteinising hormone (LH) affects ovarian androgen synthesis, folliculogenesis and oocyte development. Disturbed ovarian-pituitary and hypothalamic feedback accentuates the gonadotrophin abnormalities, and there is emerging evidence putatively implicating dysfunction of the Kiss 1 system. Within the follicle subunit itself, there are intra-ovarian paracrine modulators, cytokines and growth factors, which appear to play a role. Adrenally derived androgens may also contribute to the pathogenesis of PCOS, but their role is less defined.

Citing Articles

ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women.

Vaiarelli A, Cimadomo D, Rucci C, Innocenti F, Taggi M, Pittana E J Assist Reprod Genet. 2024; 41(12):3423-3432.

PMID: 39495342 PMC: 11707217. DOI: 10.1007/s10815-024-03299-z.


Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague-Dawley Rats.

Yusuf A, Amri M, Ugusman A, A Hamid A, Mokhtar M Int J Mol Sci. 2024; 25(18).

PMID: 39337689 PMC: 11432676. DOI: 10.3390/ijms251810202.


CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis.

Luo X, Dong Y, Zheng H, Zhou X, Rong L, Liu X J Ovarian Res. 2024; 17(1):79.

PMID: 38610028 PMC: 11015649. DOI: 10.1186/s13048-024-01407-2.


Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s.

Etrusco A, Mikus M, Damato A, Barra F, Planinic P, Goluza T Biomedicines. 2024; 12(3).

PMID: 38540265 PMC: 10967775. DOI: 10.3390/biomedicines12030653.


The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date.

Kolnikaj T, Herman R, Janez A, Jensterle M Medicina (Kaunas). 2024; 60(2).

PMID: 38399531 PMC: 10890374. DOI: 10.3390/medicina60020244.